stockrowPraxis Precision Medicines, Inc.
PRAX Healthcare Biotechnology
Praxis Precision Medicines, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $8.6 million, up 249.5% from fiscal 2023.
- Revenue
- +1,349.1%
- EPS
- +13.3%
- Free cash flow
- −43.5%
Quarter to June 2026, against a year earlier
Follow PRAX
Alert me
Praxis Precision Medicines, Inc. (PRAX) Book value per share
Praxis Precision Medicines, Inc.'s book value per share at the end of fiscal 2025 was 39.0×, up 56.9% from 24.9× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 46.0×. Over the past ten years it has ranged from −793× (fiscal 2019) to 482× (fiscal 2020); the current reading is higher than 75% of that period. Praxis Precision Medicines, Inc. ranks 15th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 39.0× | 56.86% |
| FY2024 | 24.9× | 135.44% |
| FY2023 | 10.6× | (57.34%) |
| FY2022 | 24.8× | (72.04%) |
| FY2021 | 88.6× | (81.60%) |
| FY2020 | 482× | — |
| FY2019 | −793× | — |
| FY2018 | −474× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 46.0× | (5.69%) |
| Mar 2026 | 48.8× | 25.10% |
| Dec 2025 | 39.0× | 149.64% |
| Sep 2025 | 15.6× | (16.96%) |
| 25 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| KRYS Krystal Biotech, Inc. compare | 48.5× |
| PRAX Praxis Precision Medicines, Inc. | 46.0× |
| SYRE Spyre Therapeutics, Inc. compare | 11.9× |
| CORT Corcept Therapeutics Incorporated compare | 7.8× |
| ABVX Abivax SA Sponsored ADR compare | 5.3× |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | 3.3× |
| RYTM Rhythm Pharmaceuticals, Inc. compare | 2.9× |
| AXSM Axsome Therapeutics, Inc. compare | 2.0× |
| CYTK Cytokinetics, Incorporated compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))